Arcosa, Inc. (ACA) - Form 8-K Summary
Business Context and Reporting Period
Date: June 21, 2026
Company: Arcosa, Inc. (Delaware corporation)
Event: Entry into a Material Definitive Agreement (Merger Agreement)
Counterparty: CRH Americas, Inc. ("Parent") and Neon Merger Sub, Inc. ("Merger Sub")
Arcosa, Inc. has entered into an agreement to be acquired by CRH Americas, Inc. Upon closing, Arcosa will become a wholly-owned subsidiary of Parent. The transaction involves the delisting of Arcosa's common stock from the New York Stock Exchange and NYSE Texas.
Key Financial Metrics and Transaction Terms
This filing details a proposed acquisition rather than periodic financial results. Key financial terms include:
- Merger Consideration: $150.00 in cash per share of Arcosa common stock, without interest.
- Equity Awards: Outstanding restricted stock units and restricted stock will vest and be settled in cash at the Merger Consideration rate, plus accrued dividend equivalents.
- Performance Awards: Performance-based awards will be calculated at the greater of 100% of target or actual performance achieved prior to the Effective Time.
- Termination Fees:
- Parent to Company: $371,967,952 (payable under specified circumstances, including failure to obtain regulatory clearances).
- Company to Parent: $260,377,567 (payable if the Company enters into a Superior Proposal or changes its recommendation prior to stockholder approval).
Note: The filing does not provide Arcosa's current revenue, profit, cash flow, or debt metrics. Investors should refer to the most recent Form 10-K or 10-Q for operational financial data.
Material Changes and Conditions
The transaction is subject to several material conditions that must be satisfied or waived for the Merger to close:
- Stockholder Approval: Adoption of the Merger Agreement by holders of a majority of outstanding shares.
- Regulatory Approvals: Expiration of the HSR Act waiting period and receipt of required approvals in relevant jurisdictions.
- Legal Constraints: Absence of any law or injunction prohibiting the Merger.
- Representations and Warranties: Must remain true and correct, and no Material Adverse Effect may have occurred.
The "Outside Date" for closing is June 21, 2027, subject to automatic extension of up to six months if regulatory conditions remain unsatisfied.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors has recommended that stockholders approve the Merger. The Company has agreed to a "No Shop" provision, restricting it from soliciting other offers, subject to a "Fiduciary Out" allowing the Board to consider a Superior Proposal if required by fiduciary duties.
Risks and Contingencies:
- Regulatory Remedial Actions: Parent may be required to divest assets or businesses to obtain antitrust clearance, subject to materiality thresholds.
- Termination Risks: The agreement may be terminated if conditions are not met, a Superior Proposal is accepted (triggering a fee), or a Change of Recommendation occurs.
- Operational Disruption: Risks include diversion of management attention, potential loss of key personnel, and adverse reactions from customers or suppliers.
- Forward-Looking Statements: There is no assurance the Merger will be consummated. Actual results may differ materially from expectations.
Investor Verification Checklist
- Verify the final vote count at the special stockholder meeting to confirm approval of the Merger.
- Monitor SEC filings for the definitive Proxy Statement, which will contain detailed financial data and risk factors.
- Track regulatory approval status, specifically regarding the HSR Act and any required divestitures.
- Review the full text of the Merger Agreement (Exhibit 2.1) for specific definitions of "Superior Proposal" and termination rights.
- Confirm the final settlement date and payment mechanics for equity awards and restricted stock.